June 20th 2024
Breakout session discusses the impact of incorporating decentralized elements into oncology clinical trials on data integrity, patient safety, and regulatory approvals.
Walgreens, Boehringer Ingelheim Agree to Collaboration on Enhancing Clinical Trial Diversity
May 2nd 2024Partnership expected to utilize Walgreens’ pharmacies as recruitment and trial sites for a clinical study regarding obesity, weight issues, and type 2 diabetes, mainly in historically underrepresented groups.
Enhancing Diversity Through Trial Design
April 3rd 2024In part 2 of this video interview with ACT editor Andy Studna, Tirisham Gyang, MD, assistant professor of neurology at The Ohio State University discusses how industry can effectively enroll patients from underrepresented populations into their trials.
From Words to Action: Advancing Efforts to Reduce the Racial Gap in Clinical Research
February 7th 2024Despite repeated calls from the FDA, patient advocates, and scholars for the need to address demographic disparities in clinical research, White participants still remain overrepresented while racial minority participants remain underrepresented in clinical trials.
From 'Brave Spaces' to Battling Bias in Patient Engagement
June 7th 2023In this Q&A, Ashley Moultrie, director of diversity, equity, and inclusion and community engagement for Javara shares her thoughts on current progress and remaining roadblocks in employing effective DEI strategies in clinical research.